India has crossed a significant landmark in its fight against COVID19 pandemic today. The country has administered more than 23 Cr (23,10,89,241) Vaccine Doses as per the 7 pm provision report today. Vaccination is an integral pillar of the comprehensive strategy of Government of India for containment and management of the pandemic, along with Test, Track, Treat and COVID Appropriate Behaviour. Implementation of the Liberalized and Accelerated Phase-3 Strategy of Covid-19 Vaccination has started from 1st May 2021.
16,19,504 beneficiaries of the age group 18-44 years received their first dose and 41,058 beneficiaries of the same age group received their second dose of COVID vaccine today. Cumulatively, 2,76,35,937 persons across 37 States/UTs have received their first dose and total 1,60,406 have received their second dose since the start of Phase-3 of the vaccination drive. Bihar, Delhi, Gujarat, Haryana, Karnataka, Madhya Pradesh, Maharashtra, Rajasthan, Tamil Nadu, Uttar Pradesh and West Bengal have administered more than 10 lakh beneficiaries of the age group 18-44 years for the first dose of COVID vaccine.
— Ministry of Health (@MoHFW_INDIA) June 6, 2021
The total of 23,10,89,241 include 99,62,728 Healthcare Workers (HCWs) who have taken the 1st dose and 68,53,413 HCWs who have taken the 2nd dose, 1,61,57,437 Frontline Workers (FLWs) (1st dose), 86,58,805 FLWs (2nd dose), 2,76,35,937 for 18-44 years of age group (1st dose) and 1,60,406 for 18-44 years of age group (2nd dose). 7,06,41,613 for over 45 years old to 60 years old (1st Dose), 1,12,93,868 for over 45 years old to 60 years old (2nd dose), 6,05,25,195 for above 60 years (1st Dose) and 1,91,99,839 for above 60 years (2nd Dose).
As on Day-141 of the vaccination drive (5th June, 2021), total 31,20,451 vaccine doses were given. 28,70,693 beneficiaries were vaccinated for 1st dose and 2,49,758 beneficiaries received 2nd dose of vaccine as per the provisional report till 7 P.M. Final reports would be completed for the day by late tonight.
The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.